Influence of NUCB/Nesfatin-1 Polymorphism on Treatment Response to Naltrexone/Bupropion SR in Binge Eating Disorder and Obesity. The gene discussed is NUCB2; the disease is obesity due to melanocortin 4 receptor deficiency.